Rimonabant；利莫那班SR141716；SR141716|||利莫那班T1519L

当前位置:上海陶术生物科技有限公司>产品中心>活性小分子抑制剂 > Rimonabant；利莫那班SR141716；SR141716|||利莫那班

联系我们

产品目录

仪器耗材

天然产物

试剂盒

介绍

产品展示/Products

产品名称：Rimonabant；利莫那班SR141716；SR141716|||利莫那班
产品型号：T1519L
产品产地：中国大陆
采购热度：
简介内容：Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. Its main avenue of effect is a reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved in 38 countries including the ., Mexico, and Brazil. It was rejected for approval for use in the United States.

详细内容/Content

原创作者：上海陶术生物科技有限公司

Rimonabant；利莫那班SR141716；SR141716|||利莫那班产品询价/message

同类相关产品/congeneric Product

4008200310

15002134094

工作时间

9:00-18:00

展开客服

第5年